Administration of the vaccine in a dose of 0.5 ml intramuscularly:
It is allowed to administer the vaccine subcutaneously. Intravenous administration is categorically contraindicated.
Before vaccination, an examination of the child is indicated, to exclude contact with SARS patients.
Patients should be under medical supervision for 30 minutes after administration of the vaccine.
The vaccine is intended for the prevention of purulent-septic diseases caused by the Haemophilus bacillus (Haemophilus influenzae type b strain). "Hiberix" does not prevent diseases caused by other types of Haemophilus influenzae.
Hypersensitivity to any component of the vaccine, if a neurological complication was detected after previous vaccination.
Vaccination is not given to children who have a history of convulsions, diseases accompanied by fever, as well as children who suffer from:
After vaccination can be observed:
In the presence of mechanical inclusions or a strange color of the solution, the use of the vaccine is unacceptable.
Not available